RemSleep Holdings Inc. announced it has submitted the DeltaWave mask to the FDA for 510K review. After a series of unfortunate and frustrating delays due to Covid, industry recalls, and 3rd party testing that required retesting certain tests, RemSleep is excited to announce it has submitted the Deltawave mask for FDA 510K Review.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0105 USD | +5.00% | +9.38% | -32.26% |
Apr. 16 | REMSleep Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | REMSleep Holdings, Inc. cancelled the transaction announced on September 18, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-32.26% | 15.35M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- RMSL Stock
- News REMSleep Holdings, Inc.
- RemSleep Holdings Inc. Announces Submission of DeltaWave Mask for FDA 510K Review